Cite
MLA Citation
J Ghil et al.. “FRI0198 Usability and safety of SB5 (an adalimumab biosimilar) pre-filled syringe and pre-filled pen in patients with rheumatoid arthritis.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 556–557. http://access.bl.uk/ark:/81055/vdc_100135134188.0x000061